Proven expertise for your FIH and POC trials
Conducted with speed, safety, and certainty, our early phase clinical trials involve healthy volunteers and can extend to a variety of special populations and patient groups across all therapeutic areas.
Biomarkers & Pharmacodynamic Assessments:
- Cardiac telemetry
- Holter monitoring (and QTc analysis)
- Laboratory biomarkers (incl. preparation of PBMCs)
- CSF sampling
- Pulmonary function testing
- Taste assessments
- Sleep, neurological and EEG assessments
- Scales and ratings (e.g. visual analogue scales, diaries)
- Opthalmologic assessments
- Mixed meal tolerance test/Oral glucose tolerance test
- Quantitative food intake assessements
- Genotyping
- Skin assessments (incl. digital photography and biopsy)
Therapeutic Areas:
- Cardiovascular
- Dermatology
- Endocrinology & Metabolic
- Gastrotenterology
- Haematology & Immunology
- Hepatology
- Infectious disease
- Muscoskeletal
- Nephrology & Urology
- Neurology & CNS
- Opthalmology
- Psychiatry
- Pulmonary & Respiratory
- Reproductive & Women's Health
- Rheumatology
- Rare & orphan diseases
- and more
Populations:
- Healthy volunteers
- Healthy elderly
- Post-menopausal women
- Women taking oral contraception
- Men and women of non-child-bearing potential
- Otherwise healthy obese
- Healthy smokers
- Japanese and Chinese
Patient populations can be recruited via direct advertising or in collaboration with specialists. For example, our partnership with Biorasi combines Quotient Sciences’ expertise in early clinical development with Biorasi’s global patient recruitment capabilities, for a simplified path from IND to POC. Learn more >